• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493952832300
Device Problem Occlusion Within Device (1423)
Patient Problems Cardiomyopathy (1764); Dyspnea (1816); Reocclusion (1985); Pulmonary Edema (2020); Discomfort (2330); Respiratory Failure (2484)
Event Date 06/18/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(4).It was reported that in-stent restenosis (isr) occurred.In (b)(6) 2014, the patient's qualifying condition was the admission due to myocardial infarction (mi).The patient underwent an urgent percutaneous coronary intervention (pci).The target lesion was a de novo lesion located in the mid left anterior descending (lad) with 100% stenosis.It was 24 mm long, with a reference vessel diameter of 3.0 mm.Thrombus was present.The thrombolysis in mi was(timi) 0 flow.The target lesion was treated with pre-dilatation of a 2.5mm balloon catheter at 12 atmospheres and placement of a 3.0x32mm promus premier¿ drug eluting stent.Post-dilatation was performed using a 3.5mm balloon catheter at 16 atmospheres.There was 0% residual stenosis.The thrombolysis in mi was (timi) 3 flow.Three days post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2015, the patient was diagnosed with a life- threatening non st-segment elevation myocardial infarction (nstemi), which required hospitalization.The patient experienced severe shortness of breath and some chest discomfort which began approximately 3 hours prior to admission.The patient was diagnosed with a pulmonary edema due to ischemic cardiomyopathy and respiratory failure, which required intubation.In addition, an electrocardiogram (ecg) revealed a new left bundle branch block and the patient was hypertensive.Subsequently, coronary angiography was performed and revealed a widely patent stent in the proximal portion of lad.The mid-portion of the lad, which had been previously stented with 3.0x32mm promus premier¿ drug eluting stent, had some diffuse isr with approximately 40% narrowing.No revascularization was performed.The patient was treated in the intensive care unit (icu) with mechanical ventilation, diuresis, intravenous nitroglycerin, beta blockers, an ace inhibitor, and a statin.Four days from admission, the patient was extubated.Three days later post procedure, the event was considered resolved and the patient was discharged on aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5248419
MDR Text Key32088795
Report Number2134265-2015-08290
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 06/29/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/20/2016
Device Model NumberH7493952832300
Device Catalogue Number39528-3230
Device Lot Number0017329488
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/29/2015
Initial Date FDA Received11/24/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/13/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age54 YR
-
-